Met receptor tyrosine kinase: enhanced signaling through adapter proteins

KA Furge, YW Zhang, GF Vande Woude�- Oncogene, 2000 - nature.com
The Met receptor tyrosine kinase is the prototypic member of a small subfamily of growth
factor receptors that when activated induce mitogenic, motogenic, and morphogenic cellular�…

Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature

P Camparo, V Vasiliu, V Molinie…�- The American journal�…, 2008 - journals.lww.com
We report clinicopathologic features of a large series of renal translocation carcinomas from
a multicentric study. Diagnosis was performed by cytogenetic examination of fresh material�…

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

GL Dalgliesh, K Furge, C Greenman, L Chen, G Bignell…�- Nature, 2010 - nature.com
Clear cell renal cell carcinoma (ccRCC) is the most common form of adult kidney cancer,
characterized by the presence of inactivating mutations in the VHL gene in most cases,, and�…

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

I Varela, P Tarpey, K Raine, D Huang, CK Ong…�- Nature, 2011 - nature.com
The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor
gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large�…

Exome sequencing of liver fluke–associated cholangiocarcinoma

CK Ong, C Subimerb, C Pairojkul, S Wongkham…�- Nature�…, 2012 - nature.com
Opisthorchis viverrini–related cholangiocarcinoma (CCA), a fatal bile duct cancer, is a major
public health concern in areas endemic for this parasite. We report here whole-exome�…

[HTML][HTML] An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma

A Ooi, JC Wong, D Petillo, D Roossien…�- Cancer cell, 2011 - cell.com
Fumarate hydratase (FH) mutation causes hereditary type 2 papillary renal cell carcinoma
(PRCC2). The main effect of FH mutation is fumarate accumulation. The current paradigm�…

5q–myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics

KM Eisenmann, KJ Dykema, SF Matheson, NF Kent…�- Oncogene, 2009 - nature.com
Complete loss or interstitial deletions of chromosome 5 are the most common karyotypic
abnormality in myelodysplastic syndromes (MDSs). Isolated del (5q)/5q–MDS patients have�…

Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma

D Huang, Y Ding, M Zhou, BI Rini, D Petillo, CN Qian…�- Cancer research, 2010 - AACR
The broad spectrum kinase inhibitor sunitinib is a first-line therapy for advanced clear cell
renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Unfortunately, most patients�…

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

M Takahashi, DR Rhodes, KA Furge…�- Proceedings of the�…, 2001 - National Acad Sciences
To better understand the molecular mechanisms that underlie the tumorigenesis and
progression of clear cell renal cell carcinoma (ccRCC), we studied the gene expression�…

Detection of DNA Copy Number Changes and Oncogenic Signaling Abnormalities from Gene Expression Data Reveals MYC Activation in High-Grade Papillary�…

KA Furge, J Chen, J Koeman, P Swiatek, K Dykema…�- Cancer research, 2007 - AACR
Papillary renal cell carcinoma (RCC) represents 10% to 15% of adult renal neoplasms;
however, the molecular genetic events that are associated with the development and�…